• Build Automated Visibility: Design and implement real-time dashboards that pull from existing tools (Slack, Jira) with AI-flagged risks, enabling executive leadership to track progress on all Change the Business (CTB) initiatives without manual data gathering • Create Smart Execution Frameworks: Develop standardized templates for defining success criteria, timelines, and accountability owners with AI-assisted metric suggestions, ensuring every initiative has clear definitions of done • Drive Cross-Functional Alignment: Facilitate prioritization and resource trade-offs through data-driven dependency mapping, surfacing resource conflicts early and enabling proactive resolution • Institute Intelligent Operating Rhythm: Establish weekly reviews of major initiatives with automated risk scoring and escalation protocols, reducing the need for multiple senior leaders to resolve issues • Streamline Planning & Reporting: Create auto-populated templates with AI-generated draft narratives for quarterly planning and board updates, dramatically reducing leader time spent on data gathering and slide creation • Drive Annual Planning Processes: Serve as the structured facilitator for annual planning, prioritization, and accountability, ensuring strategic initiatives are properly scoped, resourced, and tracked

• Lead RCM integrations for newly acquired practices • Manage go-live timelines, risks, and dependencies • Coordinate billing, payers, vendors, and internal teams • Configure and optimize workflows in eClinicalWorks (ECW) • Build and maintain Excel reports (pivots, formulas) • Troubleshoot issues without waiting for direction • Improve integration playbooks and repeatable processes

• Involved in supporting analytical deliverables of the CMC programs while working in conjunction with CMC team members. • Management of analytical testing in our external network, especially as it relates to GMP drug substances and drug products. • Ensuring that analytical documentation (protocols, reports, methods, COAs, change controls, etc.) are added contemporaneously to Praxis’ document management system. • Oversight and coordination of CMC stability and reference standard programs. • Direct monitoring of our external network providers that execute Analytical Development activities to ensure deliverables and continuously improve efficiency. • Supporting the design and development of phase-appropriate quality control strategies, specifications, and stability studies for drug substance and drug product. • Contribute to the overall CMC team in terms of execution. • Collaborate with other functions of Praxis CMC to establish the technical and business practices of the team.

• Engagement with investors, corporate venture arms, and financial institutions: Building and managing relationships with investors, corporate venture arms, and financial institutions, and growing GFI’s network of investor contacts. • Crafting and executing an annual strategy to position alternative protein solutions for capital mobilization to achieve scale-up, by informing stakeholders about financial and economic factors relevant to industry growth and opportunities. • Developing pathways for derisking investment in alternative proteins, including securing partnerships to explore novel capital solutions to support scale-up and commercialization and convening capital providers around specific bottlenecks. • Regularly securing and giving presentations to educate audiences on investment trends and capital mobilization challenges and opportunities in the alternative protein industry. • Collaborating across GFI and with external partners to analyze and expand the public investment landscape for alternative proteins. • Analysis & resource development: Developing, disseminating, and presenting educational materials on R&D, commercialization, and infrastructure funding needs and opportunities for alternative proteins. • Shaping the narrative around investment trends in APs through analyzing and sharing market and investment data. • Making the case for alternative protein inclusion in thematic investment strategies, including AI themes, ESG strategies and sustainability goals, and other timely or long-term topics. • Contributing to sharing information and building open-access resources regarding public investment opportunities in alternative proteins, production capacity, infrastructure opportunities and challenges, and alternative protein scale-up needs (e.g., techno-economic assessments, risk and opportunity assessments, and infrastructure analyses). • Expanding and maintaining GFI’s publicly available library of investment-related educational resources and databases. • Representing GFI at industry events and in the media to educate potential investors and the public about alternative proteins and the investment landscape in the sector. • Supervision & leadership: Supervising the Startup Innovation Lead, providing strategic direction, performance management, and professional development support, and overseeing GFI’s initiatives for engaging with startups, including developing a strategy for engaging with distressed companies. • Identifying opportunities and barriers to alternative protein investment that could be addressed through education and advocacy efforts, and developing and executing on related initiatives. • Securing an understanding of innovation ecosystem health, trends, and needs around financing APs, and sharing insights to and from startups and investors on the AP financing landscape. • Providing strategic insights to internal teams to inform corporate engagement, policy, and communications priorities related to capital mobilization. • Coordinating with affiliates to identify global financing opportunities and challenges and lead or support cross-regional initiatives. • Partnering with other NGOs or stakeholders to collaborate on joint initiatives on AP financing and capital mobilization. • Performing other duties as assigned.